|
DELTA FINANCIAL CORPORATION
WARRANT ACQUISITION AGREEMENT
THIS WARRANT ACQUISITION AGREEMENT (the "Agreement") is made as
of
August 13, 2007, by and between Delta Financial Corporation (the
"Company"), a
corporation organized under the laws of the State of Delaware,
with its
principal offices at 1000 Woodbury Road, Suite 200, Woodbury,
New York 11797 and
the purchaser whose name and address is set forth on the
signature page hereof
(the "Purchaser").
IN CONSIDERATION of the mutual covenants contained in this
Agreement,
the Company and the Purchaser agree as follows:
SECTION 1. ISSUANCE OF THE WARRANTS. Subject to the terms
and
conditions of this Agreement, the Company has authorized the
issuance of
warrants to purchase 10,000,000 shares of the Company's common
stock, par value,
$.01 per share (the "Common Stock"), in the form attached hereto
as Exhibit A
(the "Warrants"). The shares of Common Stock issuable upon
exercise of the
Warrants are referred to herein as the "Warrant Shares."
SECTION 2. AGREEMENT TO ISSUE THE WARRANTS. At the Closing
(as
defined in Section 3), in connection with the transactions
described by the
Securities Repurchase Agreement, dated August 13, 2007, by and
between
Renaissance REIT Investment Corp. and Delta Funding Corporation,
as Sellers, the
Company, as Guarantor, and the Purchaser, as Buyer, and the
documents delivered
in connection therewith (collectively, the "Financing
Agreements"), the Company
will, subject to the terms of this Agreement, issue to the
Purchaser, and the
Purchaser will acquire from the Company, upon the terms and
conditions
hereinafter set forth, the Warrants.
SECTION 3. DELIVERY OF THE WARRANTS AT THE CLOSING. The
completion of the issuance of the Warrants (the "Closing") shall
occur at the
offices of Morrison & Foerster LLP, 1290 Avenue of the
Americas, New York, New
York 10104 on August 14, 2007, or on such later date or at such
different
location as the Company and the Purchaser shall agree in
writing, but in any
event not prior to the date that the conditions for Closing set
forth below have
been satisfied or waived by the appropriate party (the "Closing
Date"). The
Purchaser and the Company shall agree on the specific time of
the Closing.
At the Closing, the Company shall deliver to the Purchaser one
or more
warrant certificates registered in the name of the Purchaser, or
in such nominee
name(s) as designated by the Purchaser in writing, representing
the Warrants and
bearing an appropriate legend, as described in Section 5.6
below, referring to
the fact that the Warrants were delivered in reliance upon the
exemption from
registration under the Securities Act of 1933, as amended (the
"Securities
Act"), provided by Section 4(2) thereof. The name(s) in which
the warrant
certificates are to be registered are set forth in the
Certificate Questionnaire
attached hereto as part of APPENDIX I.
The Company's obligation to complete the issuance of the
Warrants and
deliver such certificate(s) to the Purchaser at the Closing
shall be subject to
the following conditions, any one
<PAGE>
or more of which may be waived by the Company: (a) the
completion of the closing
of the transactions contemplated by the Financing Agreements and
(b) the
accuracy in all material respects of the representations and
warranties made by
the Purchaser (as if such representations and warranties were
made on the
Closing Date) and the fulfillment in all material respects of
those undertakings
of the Purchaser to be fulfilled prior to the Closing. The
Purchaser's
obligation to accept delivery of such certificate(s) shall be
subject to the
following conditions, any one or more of which may be waived by
the Purchaser:
(a) each of the representations and warranties of the Company
made herein shall
be accurate in all material respects as of the Closing Date,
except to the
extent that such representations and warranties contain a
materiality qualifier,
in which case they shall be accurate in all respects; (b) the
delivery to the
Purchaser by counsel to the Company of a favorable legal opinion
in
substantially the form attached hereto as EXHIBIT B hereto; (c)
the completion
of the transactions contemplated by the Financing Agreements;
(d) the execution
and delivery of the Voting and Support Agreement dated August
13, 2007 by and
among the Company, the Purchaser and the officers and directors
of the Company
holding shares of the Company's Common Stock, and certain trusts
under the
control of such officers (as identified in the Company's proxy
statement for its
2007 annual stockholder meeting, under the caption "Security
Ownership of
Certain Beneficial Owners and Management"), the Management
Rights Letter dated
August 13, 2007, and the Investor Rights Agreement dated August
13, 2007 by and
between the Company and the purchasers signatory thereto (the
"Investor Rights
Agreement"); and (e) the fulfillment in all material respects of
those
undertakings of the Company to be fulfilled prior to
Closing.
SECTION 4. REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE
COMPANY. The Company hereby represents and warrants to, and
covenants with, the
Purchaser as follows:
4.1 WARRANT ACQUISITION AGREEMENT AND WARRANTS. The Company has
full
legal right, corporate power and authority to enter into this
Agreement and to
perform the transactions contemplated hereby. This Agreement and
each Warrant
has been duly authorized, executed, and delivered by, and is a
valid and binding
agreement of, the Company, enforceable in accordance with its
terms, except as
(i) rights to indemnification hereunder may be limited by
applicable law, and
(ii) the enforcement hereof and thereof may be limited by
applicable bankruptcy,
insolvency, reorganization, moratorium, or other similar laws
relating to or
affecting the rights and remedies of creditors or by general
equitable
principles.
4.2 AUTHORIZATION OF THE WARRANT SHARES. The Warrant Shares have
been
duly authorized and, when issued, delivered and paid for in the
manner set forth
in the Warrant will be validly issued, fully paid and
nonassessable and free and
clear of all pledges, liens, restrictions and encumbrances
(other than
restrictions on transfer under state and/or federal securities
laws). The
Company has reserved for issuance all of the Warrant Shares. No
preemptive
rights or other similar rights to subscribe for or purchase any
shares of Common
Stock of the Company exist with respect to the issuance of the
Warrants by the
Company pursuant to this Agreement. No further approval or
authority of the
stockholders or the Board of Directors of the Company will be
required for the
issuance of the Warrants and/or the Warrant Shares by the
Company as
contemplated herein, except as required under the rules of the
Nasdaq Global
Market.
4.3 OFFERING MATERIALS. Neither the Company nor any person
acting on
its behalf has in the past or will hereafter take any action
independent of the
Purchaser to sell, offer for sale or
2
<PAGE>
solicit offers to buy any securities of the Company that would
result in the
initial issuance of the Warrants, as contemplated by this
Agreement, not being
exempt from the registration requirements of Section 5 of the
Securities Act.
4.4 NO OTHER REGISTRATION RIGHTS. No holder of any security of
the
Company outstanding prior to the date hereof has any right
(which has not been
waived or has not expired by reason of lapse of time following
notification of
the Company's intent to file the registration statement (the
"Registration
Statement") to be filed by it pursuant to the Investor Rights
Agreement) to
require the Company to register the sale of any security owned
by such
stockholder under the Securities Act in or in preference to the
Registration
Statement.
4.5 NO MATERIAL ADVERSE CHANGE. Except as otherwise set forth
in
Schedule 4.5 of the Disclosure Schedule provided on the date
hereof to the
Purchaser (the "Company Disclosure Schedule"), since March 31,
2007: (i) the
business of the Company and its subsidiaries has been operated
in the ordinary
course of business consistent with past practice and there has
been no Material
Adverse Change (as defined below), or any development that could
reasonably be
expected to result in a Material Adverse Change; (ii) the
Company and its
subsidiaries, considered as one entity, have not incurred any
material liability
or obligation, indirect, direct, or contingent, nor entered into
any material
transaction or agreement other than in the ordinary course of
its business;
(iii) there has been no dividend or distribution of any kind
declared, paid or
made by the Company or, except for dividends paid to the Company
or its other
subsidiaries, any of its subsidiaries on any class of capital
stock, or
repurchase or redemption by the Company or any of its
subsidiaries of any class
of capital stock; and (iv) the Company and its subsidiaries have
not sustained
any material loss or interference with their businesses or
properties from fire,
flood, windstorm, accident or other calamity not covered by
insurance. For
purposes of this Agreement, the term "Material Adverse Change"
means any
material adverse change in the condition, financial or
otherwise, or in the
earnings, business or results of operations, whether or not
arising from
transactions in the ordinary course of business, of the Company
and its
subsidiaries, considered as one entity or on the transactions
contemplated
hereby or by the agreements and instruments to be entered into
in connection
herewith, or on the authority or ability of the Company to
perform its
obligations under this Agreement.
4.6 ACCOUNTANTS. The firm BDO Seidman, LLP, which has expressed
its
opinion with respect to the consolidated financial statements
contained in the
Company's Annual Report on Form 10-K for the year ended December
31, 2006, which
will be incorporated by reference in the Registration Statement
and the
Prospectus in the form first filed with the Commission pursuant
to Rule 424(b)
of the Rules and Regulations of the Securities Act, or filed as
part of the
Registration Statement at the time of effectiveness if no Rule
424(b) filing is
required (the "Prospectus"), is a registered independent public
accountant as
required by the Securities Act and the rules and regulations
promulgated
thereunder (the "Rules and Regulations") and by the rules of the
Public
Accounting Oversight Board.
4.7 PREPARATION OF THE FINANCIAL STATEMENTS. The consolidated
financial
statements of the Company and the related notes contained in its
filings under
the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), present
fairly the consolidated financial position of the Company and
its subsidiaries
as of and at the dates indicated and the results of their
operations, cash flows
and changes in stockholders' equity for the periods therein
specified. Such
3
<PAGE>
consolidated financial statements (including the related notes)
have been
prepared in conformity with generally accepted accounting
principles ("GAAP")
applied on a consistent basis throughout the periods involved,
except as may be
expressly stated in the related notes thereto. No other
financial statements or
supporting schedules are required to be included in the
Company's Exchange Act
Reports (as defined below).
4.8 INCORPORATION AND GOOD STANDING OF THE COMPANY AND ITS
SUBSIDIARIES. Each of the Company and its subsidiaries has been
duly
incorporated or formed and is validly existing as a corporation,
limited
liability company, or trust, as applicable, is in good standing
under the laws
of the jurisdiction of its incorporation or formation and has
corporate power
and authority to own, lease and operate its properties and to
conduct its
business as described in its filings with the Securities and
Exchange Commission
(the "Commission") and, in the case of the Company, to enter
into and perform
its obligations under this Agreement. Each of the Company and
its subsidiaries
is duly qualified as a foreign corporation, limited liability
company or trust,
as applicable, to transact business and is in good standing in
each jurisdiction
in which such qualification is required, whether by reason of
the ownership or
leasing of property or the conduct of business, except for such
jurisdictions
where the failure to so qualify or to be in good standing would
not,
individually or in the aggregate, result in a Material Adverse
Change. All of
the issued and outstanding capital stock or limited liability
company interests
of each subsidiary that has been organized as a corporation or a
limited
liability company has been duly authorized and validly issued,
is fully paid and
non-assessable and is owned by the Company, directly or through
subsidiaries,
free and clear of any security interest, mortgage, pledge, lien,
encumbrance or
claim.
4.9 SUBSIDIARIES OF THE COMPANY. The Company does not own or
control,
directly or indirectly, any corporation, limited liability
company, trust,
association or other entity other (x) than the subsidiaries
listed in EXHIBIT
21.1 to the Company's Annual Report on Form 10-K for the fiscal
year ended
December 31, 2006 and (y) the trusts created in connection with
the
securitizations described in such Annual Report.
4.10 NO PROHIBITION ON SUBSIDIARIES FROM PAYING DIVIDENDS OR
MAKING
OTHER DISTRIBUTIONS. Except as otherwise disclosed in Schedule
4.10, no
subsidiary of the Company is currently prohibited, directly or
indirectly, from
paying any dividends to the Company, from making any other
distribution on such
subsidiary's capital stock, from repaying to the Company any
loans or advances
to such subsidiary from the Company or from transferring any of
such
subsidiary's property or assets to the Company or any other
subsidiary of the
Company.
4.11 CAPITALIZATION AND OTHER CAPITAL STOCK MATTERS. The
authorized,
issued, and outstanding capital stock of the Company is as set
forth in Schedule
4.11 of the Company Disclosure Schedule. The Common Stock
conforms in all
material respects to the description thereof contained in the
Company's most
recent Form 8-A filed under the Exchange Act and in the Exchange
Act Reports.
All of the issued and outstanding shares of Common Stock have
been duly
authorized and validly issued, are fully paid and non-assessable
and have been
issued in compliance with federal and state securities laws.
None of the
outstanding shares of Common Stock were issued in violation of
any preemptive
rights, rights of first refusal or other similar rights to
subscribe for or
purchase securities of the Company. Except as set forth in
Schedule 4.11, there
are no authorized or outstanding options, warrants, preemptive
rights, rights
4
<PAGE>
of first refusal or other rights to purchase, or equity or debt
securities
convertible into, exchangeable or exercisable for, any capital
stock of the
Company or any of its subsidiaries. The description of the
Company's stock
option, stock bonus and other stock plans or arrangements, and
the options or
other rights granted thereunder, set forth in the Exchange Act
Reports,
accurately and fairly presents the information required to be
shown with respect
to such plans, arrangements, options and rights.
4.12 [INTENTIONALLY OMITTED.]
4.13 AGREEMENT NOT TO OFFER OR SELL ADDITIONAL SECURITIES.
During the
period of ninety (90) days following the date of this Agreement
(the "Lock-Up
Period"), the Company will not, without the prior written
consent of the
Purchaser (which consent may be withheld in its sole
discretion), sell, offer,
contract, or grant, directly or indirectly, any option to sell,
pledge,
transfer, or establish an open "put equivalent position" within
the meaning of
Rule 16a-1(h) under the Exchange Act, otherwise dispose of,
transfer, or enter
into any transaction which is designed to, or could be expected
to, result in
the disposition (whether by actual disposition or effective
economic disposition
due to cash settlement or otherwise by the Company or any
affiliate of the
Company or any person in privity with the Company or any
affiliate of the
Company), or otherwise dispose of any shares of Common Stock or
securities
convertible into, exchangeable, or exercisable for Common Stock
("Securities")
or any securities that relates to or derives any significant
part of its value
from the Common Stock; PROVIDED, HOWEVER, that the Company may
issue (i) shares
of restricted stock or options to purchase its Common Stock
pursuant to any
stock option plan, stock bonus, or other stock plan or
arrangement approved by
the Board of Directors of the Company and that has been
disclosed to the
Purchaser as set forth in the Company Disclosure Schedule, (ii)
Common Stock
upon the exercise of such options described in clause (i), but
only if such
shares, options, or shares issued upon exercise of such options,
cannot be sold,
offered, disposed of or otherwise transferred during the Lock-up
Period without
the prior written consent of the Purchaser (which consent may be
withheld in its
sole discretion), or (iii) Common Stock issuable upon exercise
of the Warrants.
4.14 STOCK EXCHANGE LISTING. The Common Stock is registered
pursuant to
Section 12(b) of the Exchange Act, and is listed on the Nasdaq
Global Market
("Nasdaq"), and the Company has taken no action designed to, or
likely to have
the effect of, terminating the registration of the Common Stock
under the
Exchange Act or delisting the Common Stock from the Nasdaq nor
has the Company
received any notification that the Commission or the Nasdaq is
contemplating
terminating such registration or listing.
4.15 NON-CONTRAVENTION OF EXISTING INSTRUMENTS; NO FURTHER
AUTHORIZATIONS OR APPROVALS REQUIRED. Neither the Company nor
any of its
subsidiaries is in violation or default of any provision of its
charter, by-laws
or other organizational documents or is in breach of or default
(or, with the
giving of notice or lapse of time, would be in default)
("Default") under any
indenture, mortgage, loan or credit agreement, note, contract,
franchise, lease
or other instrument to which the Company or any of its
subsidiaries is a party
or by which it or any of them may be bound, or to which any of
the property or
assets of the Company or any of its subsidiaries is subject,
including, without
limitation, any agreements pertaining to, relating to or arising
in connection
with, any of the securitization transactions of the Company or
any of its
subsidiaries (each, an "Existing Instrument"), except for such
Defaults as would
not, individually or in the
5
<PAGE>
aggregate, result in a Material Adverse Change. The Company and
its subsidiaries
are in compliance with all statutes, laws, rules, regulations,
judgments, orders
and decrees of all courts, regulatory bodies, administrative
agencies,
governmental bodies, arbitrators or other authorities having
jurisdiction over
the Company or such subsidiaries or any of their respective
properties, as
applicable, including, without limitation, the provisions of the
Sarbanes-Oxley
Act of 2002, as amended ("Sarbanes-Oxley Act"), and the rules
and regulations of
the National Association of Securities Dealers, Inc. ("NASD")
and Nasdaq,
including the corporate governance requirements thereof, except
where such
non-compliance would not, individually or in the aggregate,
result in a Material
Adverse Change.
4.16 NO CONFLICTS. The Company's execution, delivery, and
performance
of this Agreement and consummation of the transactions
contemplated hereby (i)
will not result in any violation of the provisions of the
charter or by-laws of
the Company or any subsidiary, (ii) will not conflict with or
constitute a
breach of, or Default under, or result in the creation or
imposition of any
lien, charge, or encumbrance upon any property or assets of the
Company or any
of its subsidiaries pursuant to, or require the consent of any
other party to,
any Existing Instrument, except for such conflicts, breaches,
Defaults, liens,
charges or encumbrances as would not, individually or in the
aggregate, result
in a Material Adverse Change, and (iii) will not result in any
violation of any
statute, law, rule, regulation, judgment, order or decree of any
court,
regulatory body, administrative agency, governmental body,
arbitrator or other
authority having jurisdiction over the Company or such
subsidiary or any of its
properties, as applicable. No consent, approval, authorization
or other order
of, or registration or filing with, any court or other
governmental or
regulatory authority or agency, is required for the Company's
execution,
delivery and performance of this Agreement and consummation of
the transactions
contemplated hereby, except such as may be required under the
state securities
or Blue Sky laws or the by-laws and rules of the NASD.
4.17 NO MATERIAL ACTIONS OR PROCEEDINGS. Except as disclosed in
or
contemplated by the Exchange Act Reports, there is no legal or
governmental
action, suit or proceeding pending or, to the knowledge of the
Company, there
are no inquiries or investigations, nor are there any legal or
governmental
actions, suits or proceedings threatened (i) against or
affecting the Company or
any of its subsidiaries, (ii) which has as the subject thereof
any officer or
director of, or property owned or leased by, the Company or any
of its
subsidiaries or (iii) relating to environmental or
discrimination matters, which
in the case of clauses (i), (ii) or (iii) would reasonably be
expected to result
in a Material Adverse Change or adversely affect the
consummation of the
transactions contemplated hereby. Neither the Company nor any of
its
subsidiaries is a party to or subject to the provisions of any
injunction,
judgment, decree or order of any court, regulatory body,
administrative agency
or other governmental body that is reasonably expected to result
in a Material
Adverse Change, including, without limitation, any state
licensure or banking
commission.
4.18 LABOR MATTERS. No material labor dispute with the employees
of the
Company or any of its subsidiaries exists or, to the knowledge
of the Company,
is threatened or imminent. The Company is not aware of any
existing or imminent
labor disturbance by the employees of any of its third-party
contractors, that
might be expected to result in a Material Adverse Change.
6
<PAGE>
4.19 INTELLECTUAL PROPERTY RIGHTS. The Company and its
subsidiaries own
or possess sufficient trademarks, trade names, patent rights,
patents, know-how,
collaborative research agreements, inventions, servicemarks,
copyrights,
licenses, approvals, trade secrets and other similar rights
(collectively,
"Intellectual Property Rights") necessary to conduct their
businesses as now
conducted, as proposed to be conducted, as described in or
contemplated by the
Exchange Act Reports, and any respective amendments or
supplements thereto. The
expiration of any of such Intellectual Property Rights would not
be reasonably
expected to result in a Material Adverse Change. Neither the
Company nor any of
its subsidiaries has received any notice of, and has no
knowledge of, any
infringement of or conflict with asserted rights of the Company
by others with
respect to any Intellectual Property Rights, other than with
respect to any
infringement that would not reasonably be expected to result in
a Material
Adverse Change. There is no claim being made against the Company
or any of its
subsidiaries regarding any kind of Intellectual Property Right.
The Company and
its subsidiaries do not, in the conduct of their business as now
or proposed to
be conducted as described in the Exchange Act Reports, infringe
or conflict with
any right or patent of any third party, or any discovery,
invention, product, or
process which is the subject of a patent application filed by
any third party,
known to the Company or any of its subsidiaries, which such
infringement or
conflict is reasonably likely to result in a Material Adverse
Change.
4.20 ALL NECESSARY PERMITS, ETC. The Company and each
subsidiary
possess such valid and current certificates, authorizations,
licenses or permits
issued by the appropriate state, federal, or foreign regulatory
agencies or
bodies necessary to conduct their respective businesses,
including, without
limitation, all certificates, authorizations, licenses or
permits required for
the making of loans and lending operations, and (i) any such
certificate,
authorization, license or permit
|